# Next Generation Reservoir Computing (NG-RC) + ChaosFEX
## Medical Computer Vision Project Ideas for Research Publication

**Author:** Research Project Proposal  
**Date:** November 2025  
**Focus:** Underutilized Medical Imaging Datasets + Novel ML Architectures

---

## 🎯 Executive Summary

This document presents **5 cutting-edge project ideas** that combine:
- **Next Generation Reservoir Computing (NG-RC)** - Advanced nonlinear dynamics processing
- **ChaosFEX (Chaos-based Feature Extraction)** - Extracting MFT, MFR, ME, MEnt features
- **Underutilized Medical Imaging Datasets** - Rare diseases with real clinical impact
- **Hybrid ML Architectures** - CFX+ML combining chaos theory with traditional classifiers

Each project targets **rare/underutilized datasets** (NOT cancer/common diseases) and addresses **real-world clinical challenges** suitable for **high-impact research publication**.

---

## 📊 Project Ideas

### **Project 1: Rare Retinal Disease Classification using RFMiD 2.0**
**🎯 Clinical Impact: HIGH | 🔬 Novelty: VERY HIGH | 📈 Publication Potential: EXCELLENT**

#### **Problem Statement**
Current AI models focus on common retinal diseases (diabetic retinopathy, glaucoma, AMD), leaving **49 rare sight-threatening conditions** underdiagnosed. Conditions like **Optic Neuritis, Retinal Detachment, Central Retinal Artery Occlusion, Anterior Ischemic Optic Neuropathy** require immediate intervention but lack robust automated detection systems.

#### **Dataset: RFMiD 2.0 (Retinal Fundus Multi-Disease Image Dataset)**
- **Size:** 860 fundus images
- **Classes:** 49 rare + frequent retinal diseases
- **Challenge:** Multi-label, multi-class, highly imbalanced
- **Unique Aspect:** Includes sight-threatening rare pathologies ignored by other datasets
- **Access:** Publicly available on Zenodo/Kaggle

#### **Proposed Architecture: NG-RC + ChaosFEX Hybrid**

```
Input: Fundus Image (860x860 RGB)
    ↓
[Stage 1: Deep Feature Extraction]
    - Pre-trained Vision Transformer (ViT) or EfficientNet-B7
    - Extract 1024-dimensional feature vectors
    ↓
[Stage 2: ChaosFEX Transformation]
    - Map features to GLS/Logistic chaotic neurons (N=100-500)
    - Extract for each neuron:
        * Mean Firing Time (MFT)
        * Mean Firing Rate (MFR)
        * Mean Energy (ME)
        * Mean Entropy (MEnt)
    - Output: 4N-dimensional chaos feature vector
    ↓
[Stage 3: NG-RC Temporal Dynamics]
    - Next-Gen Reservoir Computing layer
    - Nonlinear vector autoregression
    - Capture temporal evolution of chaos features
    - Reservoir size: 200-400 neurons
    ↓
[Stage 4: Hybrid Classification]
    Option A: ChaosNet (Cosine Similarity)
        - Compute mean representation vectors per class
        - Assign label based on highest cosine similarity
    
    Option B: CFX+ML Ensemble
        - Random Forest (handles imbalance well)
        - SVM with RBF kernel
        - AdaBoost for rare class boosting
        - k-NN with weighted voting
        - Ensemble voting
```

#### **Key Innovations**
1. **First application of NG-RC to rare retinal disease classification**
2. **ChaosFEX captures nonlinear dynamics** in fundus images that CNNs miss
3. **Handles severe class imbalance** through chaos-based feature space transformation
4. **Interpretable features** (firing patterns, energy, entropy) for clinical validation
5. **Multi-label capability** - patients often have multiple conditions

#### **Expected Outcomes**
- **Accuracy:** 85-92% (current SOTA: ~78% for rare classes)
- **AUC-ROC:** >0.90 for rare diseases
- **Clinical Impact:** Early detection of sight-threatening conditions
- **Publication Venues:** IEEE TMI, Medical Image Analysis, Nature Scientific Reports

#### **Real-World Application**
Deploy as **AI-assisted screening tool** in:
- Rural ophthalmology clinics (limited specialist access)
- Telemedicine platforms
- Emergency departments (detecting acute conditions like CRAO)

---

### **Project 2: Pediatric Neuroblastoma Histopathology Classification**
**🎯 Clinical Impact: VERY HIGH | 🔬 Novelty: EXCELLENT | 📈 Publication Potential: VERY HIGH**

#### **Problem Statement**
**Neuroblastoma** is the most common extracranial solid tumor in children, with survival rates varying from 95% (low-risk) to <50% (high-risk). Current histopathological grading is **subjective, time-consuming, and requires expert pathologists**. Automated systems are lacking due to:
- Limited publicly available datasets
- High inter-observer variability
- Complex tissue morphology

#### **Dataset: St. Jude Cloud PeCan Platform**
- **Size:** ~9,000 pediatric solid tumor histology slides (including neuroblastoma)
- **Modality:** H&E stained Whole Slide Images (WSI)
- **Annotations:** Clinical notes, genomic data, patient outcomes
- **Access:** Data Access Request (publicly available for research)
- **Alternative:** Children's Hospital Westmead dataset (1,043 neuroblastoma images, 125 patients)

#### **Proposed Architecture: Patch-Based NG-RC with ChaosFEX**

```
Input: Whole Slide Image (WSI) - Gigapixel resolution
    ↓
[Stage 1: Patch Extraction]
    - Divide WSI into 512x512 patches
    - Filter out background/artifacts
    - Extract ~500-2000 patches per slide
    ↓
[Stage 2: Patch-Level Feature Extraction]
    - ResNet-50 or ConvNeXt pre-trained on ImageNet
    - Fine-tune on histopathology (transfer learning)
    - Extract 2048-dim features per patch
    ↓
[Stage 3: ChaosFEX Transformation (Per Patch)]
    - Map to chaotic neuron ensemble (GLS map, b=0.1-0.3)
    - Extract MFT, MFR, ME, MEnt (4 features × N neurons)
    - Captures texture complexity, cellular organization
    ↓
[Stage 4: NG-RC Aggregation]
    - Treat patches as temporal sequence
    - NG-RC processes patch sequence to capture:
        * Spatial heterogeneity
        * Tumor microenvironment patterns
        * Cellular organization dynamics
    - Output: Slide-level representation vector
    ↓
[Stage 5: Risk Stratification]
    - Multi-class classification:
        * Low-risk
        * Intermediate-risk
        * High-risk
    - CFX+ML ensemble (RF + SVM + GNB)
    - Integrate genomic features (if available)
```

#### **Key Innovations**
1. **First NG-RC application to pediatric cancer histopathology**
2. **ChaosFEX captures tissue chaos** - tumor heterogeneity, mitotic activity, necrosis
3. **Patch-sequence modeling** - NG-RC treats WSI as temporal dynamics
4. **Interpretable biomarkers** - entropy correlates with tumor aggressiveness
5. **Multi-modal fusion** - combine histology + genomics

#### **Expected Outcomes**
- **Risk Stratification Accuracy:** 88-94%
- **Prognostic Value:** C-index >0.80 for survival prediction
- **Clinical Impact:** Reduce pathologist workload, standardize grading
- **Publication Venues:** Nature Medicine, Lancet Digital Health, JAMA Oncology

#### **Real-World Application**
- **Clinical Decision Support:** Automated risk stratification at diagnosis
- **Treatment Planning:** Guide chemotherapy intensity
- **Biomarker Discovery:** Identify chaos-based prognostic features

---

### **Project 3: Macular Telangiectasia Type 2 (MacTel) Progression Prediction**
**🎯 Clinical Impact: HIGH | 🔬 Novelty: VERY HIGH | 📈 Publication Potential: EXCELLENT**

#### **Problem Statement**
**Macular Telangiectasia Type 2** is a rare, progressive retinal disease causing central vision loss. Current challenges:
- No FDA-approved treatment
- Unpredictable progression rates
- Lack of prognostic biomarkers
- Limited automated analysis tools

#### **Dataset: MacTel Project (Lowy Medical Research Institute)**
- **Size:** 5,200 OCT scans from 780 MacTel patients + 1,820 controls
- **Modality:** Optical Coherence Tomography (OCT) B-scans
- **Longitudinal:** Multiple timepoints per patient
- **Access:** Contact Lowy Medical Research Institute / University of Washington

#### **Proposed Architecture: Temporal NG-RC for Progression Modeling**

```
Input: Longitudinal OCT Scans (T0, T1, T2, ..., Tn)
    ↓
[Stage 1: OCT Feature Extraction]
    - 3D CNN (ResNet3D or I3D)
    - Extract retinal layer features:
        * Ellipsoid zone disruption
        * Cavitation patterns
        * Hyperreflective foci
    - Output: 512-dim feature vector per timepoint
    ↓
[Stage 2: ChaosFEX Temporal Encoding]
    - For each timepoint, map features to chaotic dynamics
    - Logistic map with varying parameters (r=3.6-4.0)
    - Extract MFT, MFR, ME, MEnt
    - Hypothesis: Disease progression alters chaos patterns
    ↓
[Stage 3: NG-RC Temporal Modeling]
    - Input: Sequence of chaos features [T0, T1, ..., Tn]
    - NG-RC learns disease trajectory dynamics
    - Nonlinear autoregression captures:
        * Progression velocity
        * Acceleration/deceleration patterns
        * Critical transitions
    ↓
[Stage 4: Progression Prediction]
    Task 1: Binary Classification
        - Fast progressor vs. Slow progressor
    
    Task 2: Regression
        - Predict visual acuity at T+12 months
    
    Task 3: Time-to-Event
        - Predict time to severe vision loss
    
    Classifier: CFX+ML ensemble
```

#### **Key Innovations**
1. **First NG-RC application to rare retinal disease progression**
2. **Chaos-based biomarkers** - entropy/energy changes predict progression
3. **Temporal dynamics modeling** - NG-RC captures disease evolution
4. **Personalized prognosis** - Patient-specific progression trajectories
5. **Explainable AI** - Firing patterns correlate with clinical features

#### **Expected Outcomes**
- **Progression Prediction Accuracy:** 82-89%
- **Visual Acuity Prediction:** MAE <5 ETDRS letters
- **Clinical Impact:** Guide clinical trial enrollment, patient counseling
- **Publication Venues:** Ophthalmology, JAMA Ophthalmology, IEEE JBHI

#### **Real-World Application**
- **Clinical Trials:** Identify fast progressors for intervention studies
- **Patient Monitoring:** Personalized follow-up schedules
- **Biomarker Discovery:** Chaos features as surrogate endpoints

---

### **Project 4: Choroideremia Progression Monitoring via OCT Analysis**
**🎯 Clinical Impact: VERY HIGH | 🔬 Novelty: EXCELLENT | 📈 Publication Potential: HIGH**

#### **Problem Statement**
**Choroideremia** is a rare X-linked retinal dystrophy causing progressive vision loss and blindness. Challenges:
- Gene therapy trials ongoing (need objective outcome measures)
- Slow progression requires sensitive biomarkers
- Manual OCT analysis is time-consuming
- Small patient populations limit ML development

#### **Dataset: Multi-Center Choroideremia Cohorts**
- **Primary:** Published studies (18-36 patients, longitudinal OCT)
- **Secondary:** Contact research groups (University of Oxford, Moorfields Eye Hospital)
- **Modality:** En face OCT, OCT B-scans
- **Challenge:** Small dataset (few-shot learning required)

#### **Proposed Architecture: Few-Shot NG-RC with Meta-Learning**

```
Input: OCT Scans (Limited samples per patient)
    ↓
[Stage 1: Self-Supervised Pre-training]
    - Pre-train on large OCT datasets (OCTID, Duke)
    - Contrastive learning (SimCLR, MoCo)
    - Learn general retinal representations
    ↓
[Stage 2: ChaosFEX Feature Extraction]
    - Extract features from pre-trained encoder
    - Map to chaotic neurons (GLS map)
    - Extract MFT, MFR, ME, MEnt
    - Hypothesis: Choroideremia alters retinal chaos signatures
    ↓
[Stage 3: NG-RC with Meta-Learning]
    - Model-Agnostic Meta-Learning (MAML) framework
    - NG-RC learns to adapt quickly to new patients
    - Few-shot learning: Train on 5-10 samples per patient
    - Captures patient-specific progression dynamics
    ↓
[Stage 4: Progression Quantification]
    Task 1: Retinal Preservation Area (RPA) Prediction
    Task 2: Choroidal Thickness Change Rate
    Task 3: Treatment Response Assessment
    
    Classifier: k-NN + SVM (works well with small data)
```

#### **Key Innovations**
1. **Few-shot learning for rare disease** - Overcomes small dataset limitation
2. **ChaosFEX as data augmentation** - Generates rich features from limited data
3. **Meta-learning NG-RC** - Personalizes to individual patients
4. **Objective biomarkers** for gene therapy trials
5. **Transfer learning** from common to rare diseases

#### **Expected Outcomes**
- **Progression Detection:** Sensitivity >85% with 5-shot learning
- **Treatment Response:** Detect 10% change in progression rate
- **Clinical Impact:** Accelerate gene therapy trials
- **Publication Venues:** Gene Therapy, Molecular Therapy, Ophthalmology Retina

#### **Real-World Application**
- **Clinical Trials:** Primary/secondary endpoints for gene therapy
- **Patient Monitoring:** Detect early treatment failure
- **Regulatory Approval:** Objective efficacy measures

---

### **Project 5: Multi-Modal Rare Brain Tumor Classification (Pediatric)**
**🎯 Clinical Impact: VERY HIGH | 🔬 Novelty: EXCELLENT | 📈 Publication Potential: VERY HIGH**

#### **Problem Statement**
Pediatric brain tumors include **rare subtypes** (medulloblastoma, ependymoma, ATRT) with distinct treatment protocols. Challenges:
- Histopathology alone insufficient for molecular subtyping
- Multi-modal data (histology + MRI + genomics) underutilized
- Small patient cohorts per subtype
- Urgent need for rapid, accurate diagnosis

#### **Dataset: Children's Brain Tumor Network (CBTN)**
- **Size:** Multi-modal data from 1,000+ patients
- **Modalities:**
    - Whole Slide Images (H&E histology)
    - MRI (T1, T2, FLAIR, contrast-enhanced)
    - Genomic data (RNA-seq, mutations)
- **Access:** Data Access Agreement (publicly available for research)

#### **Proposed Architecture: Multi-Modal NG-RC Fusion**

```
[Modality 1: Histopathology WSI]
    - Patch extraction (512x512)
    - ResNet-50 feature extraction
    - ChaosFEX transformation
    - NG-RC aggregation
    → Histology representation vector (H)

[Modality 2: MRI Scans]
    - 3D tumor segmentation (nnU-Net)
    - Radiomics feature extraction (shape, texture, intensity)
    - ChaosFEX transformation
    - NG-RC temporal modeling (multi-sequence)
    → Imaging representation vector (I)

[Modality 3: Genomic Data]
    - Gene expression profiles (top 1000 genes)
    - Mutation signatures
    - ChaosFEX transformation
    - NG-RC captures gene regulatory dynamics
    → Genomic representation vector (G)

[Multi-Modal Fusion]
    - Concatenate [H, I, G]
    - Cross-modal attention mechanism
    - Final NG-RC layer for integrated dynamics
    ↓
[Classification]
    - Tumor type (medulloblastoma, ependymoma, ATRT, etc.)
    - Molecular subtype (WNT, SHH, Group 3/4 for MB)
    - Risk stratification (low/high)
    
    Ensemble: RF + SVM + AdaBoost
```

#### **Key Innovations**
1. **First multi-modal NG-RC for pediatric brain tumors**
2. **ChaosFEX unifies heterogeneous data** - histology, imaging, genomics
3. **Cross-modal chaos dynamics** - Discovers relationships between modalities
4. **Molecular subtyping** - Goes beyond histology
5. **Interpretable fusion** - Identifies which modality drives classification

#### **Expected Outcomes**
- **Tumor Type Accuracy:** 92-97%
- **Molecular Subtype Accuracy:** 85-91%
- **Clinical Impact:** Precision medicine, treatment selection
- **Publication Venues:** Nature Medicine, Cell Reports Medicine, Neuro-Oncology

#### **Real-World Application**
- **Diagnostic Support:** Rapid molecular subtyping at diagnosis
- **Treatment Planning:** Personalized therapy selection
- **Prognostic Modeling:** Survival prediction

---

## 🔬 Why These Projects Are Publication-Ready

### **1. Novelty**
- **First applications of NG-RC + ChaosFEX** to these specific medical domains
- **Underutilized datasets** - Not saturated with existing research
- **Hybrid architectures** - Combining chaos theory, reservoir computing, and deep learning

### **2. Clinical Impact**
- **Rare diseases** with unmet diagnostic needs
- **Real-world applications** - Not just benchmarking
- **Addresses healthcare gaps** - Rural access, specialist shortage, rare disease diagnosis

### **3. Technical Rigor**
- **Interpretable features** - MFT, MFR, ME, MEnt have physical meaning
- **Handles small datasets** - NG-RC works with limited data
- **Multi-modal fusion** - Integrates diverse data types
- **Robust evaluation** - Cross-validation, external validation, clinical metrics

### **4. Publication Strategy**

#### **High-Impact Journals (IF >10)**
- Nature Medicine, Nature Scientific Reports
- Lancet Digital Health
- JAMA Ophthalmology, JAMA Oncology

#### **Top-Tier Medical Imaging (IF 7-10)**
- IEEE Transactions on Medical Imaging (TMI)
- Medical Image Analysis
- IEEE Journal of Biomedical and Health Informatics (JBHI)

#### **Specialized Journals (IF 5-8)**
- Ophthalmology, Ophthalmology Retina
- Neuro-Oncology
- Molecular Therapy, Gene Therapy

#### **Conference Papers (Build Momentum)**
- MICCAI (Medical Image Computing)
- CVPR/ICCV Medical Imaging Workshops
- ARVO (Association for Research in Vision and Ophthalmology)

---

## 📋 Implementation Roadmap

### **Phase 1: Dataset Acquisition (Weeks 1-4)**
1. Submit data access requests (CBTN, St. Jude Cloud, MacTel Project)
2. Download public datasets (RFMiD 2.0)
3. Set up data storage and preprocessing pipelines
4. Ethical approval (if required by institution)

### **Phase 2: Baseline Implementation (Weeks 5-10)**
1. Implement standard deep learning baselines (ResNet, ViT, EfficientNet)
2. Establish performance benchmarks
3. Analyze failure cases and dataset challenges
4. Document baseline results

### **Phase 3: ChaosFEX Development (Weeks 11-16)**
1. Implement GLS and Logistic map neurons
2. Extract MFT, MFR, ME, MEnt features
3. Validate chaos features on toy datasets
4. Optimize hyperparameters (b, initial conditions, neuron count)

### **Phase 4: NG-RC Integration (Weeks 17-22)**
1. Implement Next-Gen Reservoir Computing layer
2. Integrate with ChaosFEX features
3. Compare with traditional Echo State Networks
4. Ablation studies (ChaosFEX only, NG-RC only, combined)

### **Phase 5: Hybrid Classifiers (Weeks 23-26)**
1. Implement ChaosNet (cosine similarity)
2. Implement CFX+ML ensemble (DT, RF, AB, SVM, k-NN, GNB)
3. Compare classification approaches
4. Ensemble optimization

### **Phase 6: Evaluation & Validation (Weeks 27-32)**
1. Cross-validation (5-fold or patient-level)
2. External validation (if multiple datasets available)
3. Clinical metrics (sensitivity, specificity, AUC-ROC, F1)
4. Interpretability analysis (feature importance, attention maps)

### **Phase 7: Paper Writing (Weeks 33-40)**
1. Draft manuscript (Introduction, Methods, Results, Discussion)
2. Create figures and tables
3. Statistical analysis and significance testing
4. Peer review (internal lab review)
5. Submission to target journal

### **Phase 8: Revision & Publication (Weeks 41-52)**
1. Address reviewer comments
2. Additional experiments (if requested)
3. Resubmission
4. Acceptance and publication

---

## 🛠️ Technical Requirements

### **Hardware**
- **GPU:** NVIDIA A100 (40GB) or V100 (32GB) for WSI processing
- **RAM:** 64GB+ for large medical images
- **Storage:** 2-5TB for datasets

### **Software Stack**
```python
# Deep Learning
- PyTorch 2.0+ or TensorFlow 2.x
- timm (PyTorch Image Models)
- torchvision

# Medical Imaging
- SimpleITK, nibabel (MRI/CT)
- OpenSlide (Whole Slide Images)
- scikit-image

# Chaos & Reservoir Computing
- reservoirpy (NG-RC implementation)
- numpy, scipy (chaotic maps)

# Machine Learning
- scikit-learn (CFX+ML classifiers)
- xgboost, lightgbm (boosting)
- imbalanced-learn (SMOTE, class weighting)

# Evaluation
- scikit-learn metrics
- lifelines (survival analysis)
- matplotlib, seaborn (visualization)
```

### **Key Algorithms to Implement**

#### **1. ChaosFEX Module**
```python
class ChaosFEX:
    def __init__(self, n_neurons=100, map_type='GLS', b=0.1):
        self.n_neurons = n_neurons
        self.map_type = map_type
        self.b = b
    
    def extract_features(self, input_vector):
        """
        Extract MFT, MFR, ME, MEnt from chaotic dynamics
        """
        # Map input to initial conditions
        # Iterate chaotic map
        # Compute firing times, rates, energy, entropy
        # Return 4*n_neurons dimensional feature vector
        pass
```

#### **2. NG-RC Layer**
```python
from reservoirpy.nodes import Reservoir, Ridge

class NGRC:
    def __init__(self, reservoir_size=200, spectral_radius=0.9):
        self.reservoir = Reservoir(reservoir_size, sr=spectral_radius)
        self.readout = Ridge(ridge=1e-6)
    
    def fit(self, X_train, y_train):
        # Train NG-RC on chaos features
        pass
    
    def predict(self, X_test):
        # Predict using trained reservoir
        pass
```

#### **3. ChaosNet Classifier**
```python
class ChaosNet:
    def __init__(self):
        self.mean_vectors = {}
    
    def fit(self, X_train, y_train):
        # Compute mean representation vectors per class
        for class_k in unique_classes:
            self.mean_vectors[class_k] = np.mean(X_train[y_train == class_k], axis=0)
    
    def predict(self, X_test):
        # Compute cosine similarity with mean vectors
        # Assign label with highest similarity
        pass
```

---

## 📊 Expected Results Summary

| Project | Dataset Size | Expected Accuracy | Clinical Impact | Publication Tier |
|---------|-------------|-------------------|-----------------|------------------|
| **1. RFMiD Rare Retinal** | 860 images | 85-92% | Early detection of sight-threatening diseases | Tier 1-2 |
| **2. Neuroblastoma Histopath** | 1,000-9,000 WSI | 88-94% | Risk stratification, treatment planning | Tier 1 |
| **3. MacTel Progression** | 5,200 OCT scans | 82-89% | Clinical trial endpoints, prognosis | Tier 2 |
| **4. Choroideremia OCT** | 18-36 patients | 85%+ (few-shot) | Gene therapy trial biomarkers | Tier 2-3 |
| **5. Pediatric Brain Tumors** | 1,000+ multi-modal | 92-97% | Molecular subtyping, precision medicine | Tier 1 |

---

## 🎓 Recommended Project for Your Situation

### **Top Recommendation: Project 1 - RFMiD Rare Retinal Diseases**

**Why?**
1. ✅ **Publicly available dataset** - No access barriers
2. ✅ **Manageable size** (860 images) - Feasible for academic timeline
3. ✅ **High clinical impact** - Rare diseases with real diagnostic gaps
4. ✅ **Clear evaluation metrics** - Multi-label classification benchmarks exist
5. ✅ **Strong publication potential** - Ophthalmology + AI journals
6. ✅ **Interpretable results** - Chaos features can be validated by clinicians
7. ✅ **Novelty** - No existing NG-RC + ChaosFEX work on this dataset

### **Alternative: Project 2 - Neuroblastoma (If you want higher impact)**
- Requires data access request (2-4 weeks delay)
- More complex (WSI processing)
- Higher publication tier potential (Nature/Lancet)
- Stronger clinical collaboration opportunities

---

## 📚 Key References to Read

### **ChaosFEX & ChaosNet**
1. Harikrishnan NB, et al. "ChaosFEX: A chaos-based feature extractor for enhancing the performance of EEG classifiers" (2019)
2. Harikrishnan NB, et al. "ChaosNet: A chaos based artificial neural network architecture for classification" (2020)

### **Next Generation Reservoir Computing**
3. Gauthier DJ, et al. "Next generation reservoir computing" (Nature Communications, 2021)
4. Griffith A, et al. "Forecasting chaotic systems with very low connectivity reservoir computers" (Chaos, 2019)

### **Medical Imaging + Reservoir Computing**
5. Recent papers on reservoir computing for stroke MRI analysis (2024)
6. Physical reservoir computing for blood glucose prediction (2024)

### **Rare Disease Datasets**
7. RFMiD 2.0 dataset paper (MDPI, 2023)
8. St. Jude Cloud PeCan platform documentation
9. CBTN data portal documentation

---

## 🚀 Next Steps

1. **Choose your project** (Recommend Project 1 or 2)
2. **Download/request dataset**
3. **Set up development environment**
4. **Implement baseline models**
5. **Develop ChaosFEX module**
6. **Integrate NG-RC**
7. **Write paper as you go** (Methods section early)
8. **Seek clinical collaborators** (Ophthalmologist/Oncologist for validation)

---

## 💡 Additional Tips for Publication Success

### **1. Strong Clinical Collaboration**
- Partner with domain experts (ophthalmologists, pathologists, oncologists)
- Validate findings with clinical ground truth
- Include clinicians as co-authors

### **2. Rigorous Evaluation**
- Use clinically relevant metrics (not just accuracy)
- External validation on independent datasets
- Statistical significance testing
- Confidence intervals and error bars

### **3. Interpretability & Explainability**
- Visualize chaos features (t-SNE, UMAP)
- Attention maps for deep learning components
- Feature importance analysis
- Clinical correlation studies

### **4. Open Science**
- Release code on GitHub
- Share pre-trained models
- Contribute to medical imaging community
- Participate in challenges (MICCAI, Kaggle)

### **5. Incremental Publication Strategy**
- Conference paper first (MICCAI, CVPR workshop)
- Journal paper with extended results
- Follow-up papers on specific aspects

---

## 📧 Contact & Collaboration

For dataset access, reach out to:
- **RFMiD:** Zenodo/Kaggle (public)
- **St. Jude Cloud:** https://www.stjude.cloud/
- **CBTN:** https://cbtn.org/
- **MacTel Project:** Lowy Medical Research Institute

Good luck with your research! 🎉

---

**Document Version:** 1.0  
**Last Updated:** November 2025  
**License:** For academic research use
